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Great improvements in patient selection, surgical techniques, perioperative care, and immunosuppression have 
been made for the optimization of liver transplantation. To increase the number of organs available for liver 
transplantation, transplant centers have used marginal donors, split livers, living donors, or non-heart-beating 
donors (NHBDs). Despite recent enthusiasm for NHBDs in liver transplantation, warm ischemic injury to recovered 
organs has been an obstacle for the wide acceptance of NHBD. In the present case, we have conducted a liver 
transplantation from a Maastricht Category 4 NHBD. Warm ischemic time was 20 minutes and cold ischemic time 
was 5 hour 43 minutes. Consequently, the liver was successfully transplanted into the recipient. (Korean J Anesthesiol 
2010; 59: S119-S123)
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    Since the inception of liver transplantation, multiple methods 
such as split liver transplantation from brain death donors, 
liver transplantation from living donors and marginal donors 
[1] have been employed to expand the pool of liver donors 
which are in short supply, to address the increasing demand of 
recipients. Among the marginal donors, a non-heart-beating 
donor (NHBD) refers to an individual for whom cardiac death 
has been pronounced accompanied with nerve damage, while 
heart-beating donor (HBD) refers to individuals who have been 
declared as brain dead.
    We performed anesthesia for liver transplantation on a non-
heart-beating donor (NHBD) whose organ was removed by the 
waiting surgical team when the donor in brain death underwent 
cardiac arrest in the operating room. We report the experience 
of liver transplantation anesthesia with a review of the relevant 
literature.
Case Report
    A 49-year-old, 70 kg, 175 cm tall male donor was admitted 
to the operating room (OR) at 21:20 for organ donation after 
he was declared brain dead due to hypoxic brain injury. 
Ventilation was performed with a tidal volume of 450 ml, tidal 
rate of 30/min and positive-end expiratory pressure (PEEP) S120 www.ekja.org
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of 5 cmH2O. Norepinephrine 1.5 μg/kg/min, vasopressin 2.4 
U/hr, dopamine 30.4 μg/kg/min, and dobutamine 57 μg/kg/
min were initially provided at the intensive care unit (ICU) 
and continuously administered. On admission, measurement 
taken at the radial artery showed blood pressure (BP) of 86/56 
mmHg, central venous pressure (CVP) of 16-17 mmHg, cardiac 
rate of 120/min, oxygen saturation (SO2) of 93% and partial 
pressure of end-tidal carbon dioxide (PETCO2) of 28 mmHg. 
Arterial blood gas analysis performed at 21:30 indicated a pH of 
7.310, partial pressure (tension) of oxygen (PO2) at 60.7 mmHg, 
CO2 tension at 30.4 mmHg, oxygen saturation (SO2) of 91%, 
bicarbonate 15.0 mmol/L, base excess -10.3 mmol/L, Na
+/K
+/
Cl
- 134.1/4.4/115 mmol/L, hemoglobin at 7.8 g/dl, hematocrit 
(Hct) 23% and a blood glucose (sugar) level of 144 mg/dl. 
Following measurements taken at 21:40, when BP was 45/32 
mmHg; CR, 112/min; SO2, 88%; PETCO2, 20 mmHg, an increase 
of fluid intake was established and 20 μg of epinephrine was 
administered. Thereafter, systolic blood pressure increased to 
50-60 mmHg and the surgeon was consequently informed 
of the patient’s critical condition, which initiated the start of 
the operation. Shortly in to the procedure, when pulsation 
of the carotid artery was palpable and weakened, 500 μg of 
epinephrine was injected, but this administration proved to 
be ineffective. At 21:45, the patient displayed asystole (cardiac 
standstill) and 1,000 μg of epinephrine was administered, which 
made no effect and cardiopulmonary resuscitation (CPR) was 
consequently initiated. During continuous CPR, additional 
administration of epinephrine at of the following doses, 1,000 
μg, 2,000 μg, and 2,000 μg was given. Until the occurrence 
of aortic occlusion, a fluid therapy of 1,000 ml of crystalloid 
solution and 1,000 ml of colloid solution was delivered. The BP 
of the patient did not respond to the fluid therapy since it was 
maintained at 52-58/36-40 mmHg, SO2 at 50-70%. At 22:00 
when perfusion was performed simultaneously with aortic 
occlusion, CPR was terminated. The perfusion was completed 
at 22:17 and the liver was retrieved at 22:45 (Table 1).
    The retrieved liver was transplanted to a male recipient in a 
state of hepatic coma, who was 38 years old, 75.8 kg in weight, 
181.1 cm in height, and with the Model for End-Stage Liver 
Disease (MELD) scores of 40. While his femoral arterial and 
venous pressure were monitored, a 9-Fr catheter (Advanced 
venous access HF
Ⓡ, Edwards Life Science Corporation, USA) 
and a multifunctional pulmonary artery catheter (Swan-Ganz 
CCOmbo CCO/SvO2, Edwards Life Science Corporation, USA) 
were placed into the internal jugular vein. At the onset of 
operation, dopamine 5.0 μg/kg/min and norepinephrine 0.05-
0.1 μg/kg/min were injected. At 3 hours and 20 minutes after 
anesthesia induction, the patient entered the anhepatic phase, 
and 1 hour and 3 minutes later, reperfusion was performed. 
At the time of reperfusion, an abnormality appeared when the 
patient’s BP decreased to 78/40 mmHg, CR to 75/min, but the 
administration of epinephrine 50 μg once and atropine 0.5 mg 
twice restored these to normal states. Intra-operative BP, except 
for the reperfusion period, was maintained at a relatively stable 
state of BP between 95-130 and 44-70 mmHg, CR between 
75/min and 98/min (Table 2). After the liver transplantation, 
which lasted 7 hours-and-50 minutes, was completed, the 
patient’s vital signs indicated BP 109/59 mmHg, CR 86/min, and 
SO2 100%. He was then transferred to the intensive care unit 
(ICU), when dopamine 5.0 μg/kg/min and norepinephrine 0.3 
μg/kg/min were administered as vasopressor. All of the intra-
operative intakes of fluid and blood products included 4,900 
ml of crystalloid solution, 880 ml of 5% glucose solution, 1,500 
ml of colloid solution, 1 unit of packed leukocyte-depleted 
red blood cells (RBC), 4 units of fresh frozen plasma (FFP), 6 
units of cryoprecipitates, 500 ml of 5% albumin, and 1,108 ml 
of retrieved blood by cell saver, while the urine output was 115 
ml; ascites, 3,000 ml; blood loss, 2,000 ml. On postoperative day 
3, the patient occasionally displayed convulsive motions, but 
was able to respond to instructions. On postoperative day 6, the 
endotracheal tube was removed, and on postoperative day 12 
he was transferred to the general ward. On postoperative day 
61, he was finally discharged home.
Discussion
    Brain dead patients undergo deterioration of the metabolic 
function of other organs before determination of brain death 
and 80% of them incur cardiac death within 120 hours because 
cardiopulmonary function is degenerated despite active treat-
Table 1. Vital Signs and Events during Liver Extraction from NHBD
21 : 20 21 : 25 21 : 30 21 : 35 21 : 40 21 : 45 22 : 00 22 : 17 22 : 45
BP(S/D) (mmHg)
HR (/min)
SpO2 (%)
ETCO2 (mmHg)
Events
86/56
120
  93
  28
92/54
124
  95
  30
130/74
126
  96
  30
ABGA
102/64
120
  99
25
45/32
112
  88
  20
EPI 20 μg
Asystole
-
-
-
CPR start
perfusion start
-
-
-
CPR finish
perfusion finish
-
-
-
Liver harvest
-
-
-
BP (S/D): blood pressure (systolic/diastolic), HR: heart rate, SpO2: O2 Saturation, ETCO2: end tidal CO2, ABGA: arterial blood gas analysis, EPI: 
epinephrine, CPR: cardio-pulmonary resuscitation.S121 www.ekja.org
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ments [2]. Metabolic disorder and hematologic deterioration 
causes cardiac arrest. Therefore, the most important goal of 
managing deceased organ donors is to maintain hematologic 
stability and physiological balance. Hypovolemia, hypothermia, 
endogenous hormonal changes, left ventricular failure and 
other similar conditions cause hypotension for a majority of 
brain dead individuals, which contributes to cardiac output 
decrease, myocardial impairment, decrease of afterload 
and other similar symptoms. To confront hypotension, 
fluid administration of crystalloid and colloid solutions or 
blood transfusion is performed to correct hypovolemia and 
increase urine output. If low blood pressure sustains even after 
hypovolemia is corrected, dopamine should be administered 
primarily and other drugs such as norepinephrine, epinephrine, 
vasopressin and dobutamine also should be used to maintain 
BP within the normal ranges. The guidelines of anesthesia 
management for brain dead people published in 1990 states the 
maintenance of systolic blood pressure >100 mmHg (median 
BP 70-110 mmHg), arterial oxygen tension (PaO2) >100 
mmHg, urine output >100 ml/hr (1-1.5 ml/kg/hr), hemoglobin 
>10 g/dl, and central venous pressure (CVP) at 5-10 mmHg 
[3]. Since lung transplantation teams favor a low CVP, while 
liver transplantation teams prefer a high CVP, it is important to 
maintain a proper CVP for the different types of donated organs. 
As for liver transplantation, maintenance of CVP under 10 
mmHg is recommended due to the effects of hepatic edema on 
transplantation. During bradycardia in brain dead individuals, 
atropine does not result in significant responses, therefore the 
use of direct-acting chronotropic drugs such as isoproterenol 
and epinephrine is required and CPR should be ready to apply 
to address incidences of cardiopulmonary arrest. 
    For heart-beating donors (HBD), warm ischemic injury, which 
occurs between cardiac arrest and the onset of organ perfusion, 
is adequate because ventilation and pulsation is applied 
immediately prior to the organ removal [4]. For non-heart-
beating donors (NHBD), where the retrieval of organs follows 
cardiac death, the degree of warm ischemic injury varies between 
organs, therefore postoperative results of liver transplants 
fluctuate, leaving the patient vulnerable to delayed primary graft 
nonfunctioning or complete graft nonfunctioning [4]. 
    Non-heart-beating donors (NHBD), who are declared dead 
due to cardiopulmonary function effacement have been 
classified into 4 categories according to the Maastricht criteria 
determined at the Maastricht Workshop in 1994 [5]. In the 
Table 2. Hemodynamic Datas and Laboratory Results during Liver Transplatation
Time Pre-op I + 60’ I + 120’ I + 180’ II + 60’ III + 5’ III + 30’ III + 60’ III + 120’
ICU
arrival
Hemo-
  dynamics
ABGA
Electrolytes
Hematology
Coagulation
HR (rate/min)
BP (S/D(M))
  (mmHg)
CVP/FVP
  (mmHg, mmHg)
PCWP/EDV
  (mmHg,ml)
CO/ RVEF
  (L/min, %)
pH
PaCO2 (mmHg)
PaO2  (mmHg)
HCO3
-
 (mmol/L)
BE (mmol/L)
Na
+ (mmol/L)
K
+ (mmol/L)
Ca
2+ (mmol/L)
Glu (mg/dl)
Lactate (mmol/L)
Hb (g/dl) 
Hct (%) 
Platelets (1,000/μl)
PT (INR) 
aPTT (sec)
ACT (sec)
Fibrinogen (mg/dl)
65
115/68
(-)
-
-
-
7.54
35
82
30
-
142
4.0
1.2
120
1.7
7.7
25.1
71K
4.77
62.1
-
120
78
116/60
(82)
15/17
22/310
10.7/45
7.42
45
166
29
4.4
141
3.6
1.2
96
1.4
9.6
31.2
55K
6.15
70.3
201
115
80
128/69
(91)
12/19
16/276
9.5/45
7.43
42
134
27
3.2
141
3.8
1.1
90
1.5
9.8
29
-
-
-
-
78
125/64
(86)
9/17
11/224
9.0/52
7.43
40
126
26
2.2
140
3.8
1.0
94
1.7
8.8
28.5
52K
4.46
83.5
-
109
74
96/51
(68)
9/14
11/316
12.6/52
7.51
31
168
25
2.1
138
3.8
1.0
103
2.1
7.0
22.9
43K
6.19
92.3
-
73
75
91/44
(62)
10/14
18/317
12.3/51
7.42
36
311
23
-0.4
137
3.9
1.0
119
3.6
6.8
22.0
46K
7.08
96.1
203
58
86
115/55
(77)
12/14
16/303
13.2/52
7.45
34
108
23
0.0
139
3.9
1.0
117
3.2
7.8
23
-
-
-
-
87
101/46
(66)
8/14
10/240
10.2/50
7.41
36
161
23
-1.3
138
4.1
1.0
120
3.1
8.2
26.3
46K
3.90
98.8
215
62
83
113/51
(73)
10/13
17/265
10.6/47
7.35
44
97
24
-1.6
139
4.3
1.1
110
2.7
9.3
27
-
-
-
-
86
109/59
(-)
-
-
-
7.38
40.7
98.7
23.5
-1.5
139
4.6
1.1
113
-
9.3
30.3
43K
2.81
62.7
-
123
Pre-op: pre-operation, I: preanhepatic period, II: anhepatic period, III: post-reperfusion period, ICU: intensive care unit, ABGA: arterial blood 
gas analysis, PT: prothrombin time, INR: international normalized ratio, aPTT: actvated partial thromboplastin time, ACT: activated clotting 
time, CVP: central venous pressure, FVP: femoral vein pressure, PCWP: pulmonary capillary wedge pressure, EDV: end diastolic volume, CO: 
cardiac output, RVEF: right ventricle ejection fraction. S122 www.ekja.org
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division of uncontrolled NHBD, including category 1 and 2, 
category 1 refers to ‘dead on arrival’ whereas category 2 refers 
to death due to unsuccessful cardiopulmonary resuscitation 
(CPR). On the other hand, in the division of controlled NHBD, 
including category 3 and 4, category 3 means the status of 
readiness of organ retrieval from a donor who is brain dead 
and whose life support system is withdrawn with consent by 
the patient’s next of kin for organ donation. Immediately after 
cardiopulmonary function ceases when the administration of 
medicine and respirator aid to the donor are terminated, the 
waiting surgical team recovers the organs. Category 4 refers to 
cardiac arrest occurring to a brain dead donor [5]. Therefore, 
the majority of organ transplantation centers prefer controlled 
NHBD, so donors of category 3 constitute the majority of 
NHBDs. The NHBD in the present case belongs to category 4. 
    Transplantation form NHBDs is growing in importance as 
a promising means to increase the number of organ donors 
from approximately 10% up to 20% or higher [4]. As for renal 
transplantation from NHBDs, dysfunction of an implanted 
kidney does not present a serious problem because kidney 
dialysis can be employed as an auxiliary method. Liver 
transplantation form NHBDs, however, is highly susceptible 
to complications of the vascular and biliary systems, which 
potentiates the risk of surgery as the most effective alternative. 
According to Foley at al., the incidence of hepatic artery throm-
bosis reached 16.6% while the incidence of biliary stenosis 
came to 13.8% [6]. Maheshwari et al. [7] reported that the 
incidence of ischemic type biliary lesion rose to 50%. Early data 
from Casavilla et al. [8] showed the 1-year graft survival rate was 
20%, while recent data released by American United Network 
of Organ Sharing revealed that the 3-year survival rate was 63%, 
which is a remarkable improvement, comparable with 72% 
survival rate of HBD. In England, where NHBDs constitute 14 
% of the total transplantations, 1-year graft survival rates from 
NHBDs have been reported to amount to 80% [9].
    Even though there have been many reports on increases in 
organ graft survival from NHBDs, there is still concern about 
organ graft nonfunctioning, primarily because warm ischemic 
injury was inevitable due to hypotension and circulatory arrest 
after the cessation of cardiac pulsation. In order to increase 
graft survival rate, warm ischemic time (WIT) should be within 
30 minutes while donor age should be ≤ 40 years and cold 
ischemic time (CIT) should be < 8 hours [9,10]. A study reported 
that engraftment failure rate increased to 60 % in the case of CIT 
>12 hours while the engraftment failure rate decreased to 10% 
or below in the case of CIT ≤ 8 hours [11]. 
    According to a report by Monbaliu et al. [12] in 2007, 
between January 1
st, 2003 and November 30
th, 2005, 16 of 642 
liver transplantations from brain dead people (2.45%) were 
performed from NHBD, one case among which was Maastricht 
category-4 NHBD. They defined warm ischemic time (WIT) as 
the time between ventilator switch-off time and the onset of 
organ perfusion, and thus comparing WIT <30 minutes and 
WIT > 30 minutes, they reported that the incidence of biliary 
complications in case of WIT >30 minutes was 37.5% higher 
than in case of WIT <30 minutes. Many agree that it is ideal to 
keep WIT to less than 30 minutes [13], but the definition of WIT 
differs from transplant center to center. Some transplant centers 
have defined WIT as the time between the start of decrease in 
systolic arterial pressure and the onset of organ perfusion [14]. 
What is noteworthy in the episode experienced by Monbaliu 
et al. [12] where even though primary graft nonfunctioning did 
not develop in liver transplantation from Maastricht category-4 
NHBDs, malfunction of the graft was detected immediately 
after liver transplantation and hepatic artery thrombosis 
occurred, with WIT of 50 minutes. If WIT is regarded as the 
ischemic injury time due to hypotension and circulatory arrest 
following the cessation of cardiac pulsation, WIT can be defined 
as the time between systolic arterial pressure decrease to 50 
mmHg or below and the start of organ perfusion. Based on 
this, if time is measured from the moment of systolic arterial 
pressure decrease to 50 mmHg or below, WIT in the our case is 
20 minutes and does not exceed 25 minutes, even considering 
that a decrease in BP starts beforehand. In addition, CIT in the 
present case was 5 hours and 43 minutes. In retrospect, we had 
positive results due to the short periods of WIT and CIT. 
    To reduce warm ischemic periods (WIT) in NHBDs, there 
have been a variety of attempts made such as cardiopulmonary 
bypass (CPB), extracorporeal membrane oxygenation, and 
surgically, super rapid retrieval as a modification of the en bloc 
multiorgan harvest technique [8]. Simultaneously, to increase 
graft survival rate in recipients, it is critical to avoid prolonged 
surgical periods of dissection and excision, to keep vital signs 
within the stable ranges, and to maintain the vitality of organs 
[15]. It should also be taken into consideration that a prolonged 
WIT would aggravate a coagulation defect after reperfusion and 
cause acid-base imbalance.
    Utilization of non-heart-beating donors (NHBDs) for the 
potential pool of organ donors requires organizing teams of 
seasoned surgeons and anesthesiologists, a change toward 
enhanced public awareness and acceptance of donating 
organs, and the legal and institutional framework for support 
at government level. Such efforts to increase the number 
of NHBDs are expected to expand the potential pool by 
up to 30-40% in the near future [15]. With improvements 
in immunosuppression and preservation of organs, and 
establishment of standardized surgical skills for transplantation, 
NHBDs will contribute to expanding the donor pool and 
will supplement the donor pool by 20%, even though NHBD 
cannot replace HBD [15]. Also, future endeavors to manipulate S123 www.ekja.org
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ischemic injury and to access engraftment will bring benefits 
for expanding the pool of organ donors by NHBD. Considering 
the current trend toward NHBD, we tried to refine the notion of 
NHBD using experiences of anesthesia for non-heart-beating 
donors and liver transplantation. We hope that this study 
will help many centers expand the criteria of the donor pool, 
henceforth. 
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